|
|
|
|
| LEADER |
01585nam a22003975i 4500 |
| 001 |
000285737 |
| 005 |
20210824163649.0 |
| 007 |
cr nn 008mamaa |
| 008 |
141218s2015 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319096650
|
| 024 |
7 |
|
|a 10.1007/978-3-319-09665-0
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a High Density Lipoproteins :
|b From Biological Understanding to Clinical Exploitation /
|c edited by Arnold von Eckardstein, Dimitris Kardassis.
|
| 250 |
|
|
|a 1st ed. 2015.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2015.
|
| 300 |
|
|
|a XIII, 694 p. 40 illus., 37 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Handbook of Experimental Pharmacology,
|v 224
|
| 505 |
0 |
|
|a Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.
|
| 506 |
0 |
|
|a Open Access
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Molecular biology.
|
| 650 |
|
0 |
|a Human physiology.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Cell biology.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Molecular Medicine.
|
| 650 |
2 |
4 |
|a Human Physiology.
|
| 650 |
2 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Cell Biology.
|
| 700 |
1 |
|
|a von Eckardstein, Arnold.
|e editor.
|
| 700 |
1 |
|
|a Kardassis, Dimitris.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|